Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL)

Clinical trial NCT00336583 · COMPLETED

Trial details

NCT number: NCT00336583
Sponsor: Asan Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2006-06-01
Primary completion: 2006-12-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.